Missing/wrong data?
Log in to edit
C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the north central cancer treatment group N9831 adjuvant trastuzumab trial.
scientific article
Author/s
author: Amylou Dueck, Rhett P. Ketterling, Edith A. Perez, George Sledge, Wilma L Lingle, James N Ingle
Work details
Publication date
January 18, 2011
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.